chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child received immunization on 8/5/2020 during a vaccination clinic per County Public Health.  Mother called County Public Health office Friday AM 8/7/2020 reporting child's arm was very redden, warm to touch and painful.   Public Health nurse instructed mother to take child into the clinic  and have arm evaluated.   Child was seen by FNP in clinic 8/7/2020 @10:30 AM. Diagnosis was allergic reaction to vaccine .   Treatment: prenisolONE 15 mg/15 ml solution 1 tsp. by mouth BID for 5 days and  DiphenhydraAMINE 12.5mg / 5ml Take 2.5 ml by mouth  every 4 hours as needed for itching or allergies.
Left arm with erythema, swelling (vertical) complaint of itching- size appox. 70 mm wide x 60 mm long (area)
All over joint pain, specifically neck and hand pain, stiffness, swelling, redness.  Immobility of joints.  Treated in ER x 2.  Spinal tap, MRI of neck.  Currently on prednisone prescribed by primary care MD.  Has been on steroids for 6 weeks. Out of work for almost 3 weeks and unable even now to return to full schedule.
Information has been received from a consumer concerning her friend who was vaccinated with a dose of PNEUMOVAX 23 (name and manufacturer unspecified) and had a severe reaction as well and was paralyzed for a week. No further information is provided. Upon internal review, paralysis was determined to be other important medical events. This is one of several reports from the same source. Additional information has been requested.
This spontaneous report as received from a doctor of pharmacy refers to a currently 81 years old female patient with no drug reactions or allergies. The patient was vaccinated subcutaneously with a premeasured dose of lot # (671663/1159AA; exp date 18-Oct-2012) ZOSTAVAX on 15-JUN-2012 (dose not provided). No other co-suspects were reported. Concomitant medications included amlodipine, LASIX, PLAQUENIL, SPIRIVA, fluticasone propionate, ADVAIR, ZOCOR and DHEA. On an unknown date the patient had fever, malaise and chills. The patient visited the pharmacy and no treatment was given for the reported events. The outcome of fever, malaise and chills was reported as recovered (date unknown). The relatedness for fever, malaise and chills was not provided for ZOSTAVAX.
PT HAS HX TONGUE SWELLING AND FACIAL NUMBNESS/TINGLING WITH FIRST DOSE. HERE TODAY FOR SECOND DOSE. DR APPROVED. PT RECEIVED SECOND DOSE OF PFIZER, DEVELOPPED SAME SYMPTOMS BUT MILD THIS TIME, VSS, WAS PREMEDICATED WITIH BENADRYL AND PEPSID, REFUSED TRANSPORT, DRIVEN HOME BY FRIEND, WILL GO TO ER AS NEEDED.
Hives which were treated w/steroids; also swelling of mouth & nose; arthralgias; knees, swollen, fatigue, low grade fever;
Pt recv vax on 12/7/98; on same day pt exp welts on face, ears, neck, chest, back, mouth & groin; irritable; body twitching
Fatigue; she is out of breath; can't eat because she has nausea; can't eat because she has nausea; has lost over 30 pounds; I can't feel anything; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received second dose of bnt162b2 (COMIRNATY, solution for injection), via an unspecified route of administration on 12May2021 as single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date the patient had side effects after second dose such as fatigue, out of breath (dyspnoea), she can't eat because she had nausea and she had lost weight over 30 pounds. The patient was feeling fine before after took this shot and stated should have never taken the vaccine. It changed my life genetically and can't feel anything. The outcome of events was unknown.
On November 15th I had my mammogram and sonogram.  The result showed that I've a grape size swollen lymph node under my left arm pit.  It wasn't there in 2030 when I did my yearly mammogram.  I was then told that several women are experiencing the same problem after having the vaccines.  My first vaccine was 1.8.21. The second was 2.5.21 and my booster was 11.8 21. My mammogram and sonogram was done November 15th 2021. I had a second sonogram done February 17th and was told that the lymph node is still swollen and that I've to come back in 6 months. I was told that it should've gone down  but it's still there.  So what do I do now?
After about 10 minutes after the patient recieved the vaccine, the patient started itching all over and started to break out in a rash. The patient was given benadryl 50mg IM and the symptoms started to subside.
Started with cough 1900 15MAR09, progressed to headache, nausea, sore throat, tachycardia, fever (103 degrees F), muscle ache, general weakness and dizziness on standing. Also, wheezing.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 at 13:00 as dose 2, single (Lot number: GJ2524) at the age of 66 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 10May2022 at 13:00 as dose 1, single (Lot number: FM9992), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "knee replacement surgery", start date: 20Jul2023 (not ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, Covid-19 with PAXLOVID from 30Sep2023 to 04Oct2023. Clinical course: Patient had no known allergies.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300328723 same reporter/patient, different product/AE;
Daughter started screaming and had to be admitted to hospital.  She was diagnosed with seizures.
In patient's own words: "woke up 8/31/18 with muscle paralysis on right side of face. Went to ER at 6:00pm to rule out stroke and was diagnosed with Bell's Palsy. Received rx for eye drops, valacyclovir and prednisone".
I am HLA-27 deficient; iritis flared up; iritis flared up; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN6204), via an unspecified route of administration administered in left arm on 19Mar2021 at 11:15 AM (at the age of 59-year-old) as SINGLE DOSE for COVID-19 immunisation. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and was not COVID tested post vaccination. Medical history included known allergies to some flours, depending on processing and iritis (significant period of stability). Concomitant medication included brimonidine tartrate. The patient stated, "It may be coincidental, but my iritis flared up 48 hrs after Vaccination, following a significant period of stability. It only lasted 4 days, so a relatively short episode. No visit to doctor was required. I am HLA-27 deficient." The events started on 21Mar2021. The reporter considered the event "I am HLA-27 deficient" as serious medically significant. There was no treatment received for the events. On an unspecified date, the patient recovered from all events.
This spontaneous report as received from a patient's mother reporting on her 11 year old female daughter (currently 16 year old) with no drug reactions or allergies and no pertinent medical history. In March 2007, the patient was vaccinated with the first dose, on an unknown date with the second dose, and in November 2009 with the third dose of GARDASIL, shot in the arm (doses, routes, lot numbers not reported) respectively. No other co-suspects were reported. Concomitant medications included: ibuprofen. From the beginning, from March 2007, the patient passed out, got migraine, headaches and need to see a heart specialist. The patient got "all of the side effects listed". The patient had been missing a lot of school because of this and had been detained by one year as well. There was no treatment given for adverse events. No laboratory tests were performed. At the time of the report the patient's outcome was unknown. Missing a lot of school was related to GARDASIL. The relatedness for passing out, migraine, headaches, need to see a heart specialist and all of the side effects listed was not reported for GARDASIL. The patient sought medical attention. Upon internal review, missing a lot of school by the patient was determined to be disabling. Additional information has been requested.
Booster dose (3rd time getting).  Patient reports she believes the shot was given too low resulting in a lump, sore arm, itchiness and being sick to her stomach.  She had no problems after the two previous doses.   Symptoms started that night or by the next day.  She says her arm is still sore and is self treating with Tylenol and putting rubbing alcohol on her arm to help with the itchiness.
@1305PATIENT VERBALIZED "I FEEL LIKE I AM HAVING HEART PALPITATIONS" AND APPEARED VERY ANXIOUS M/B JITTERY FEET.  UPON ASSESSMENT VITAL SIOGNS WERE STABLE.  BLOOD PRESSURE: 132/64 PR= 82, RR18, AFEBRILE. PATIENT ALSO VERBALIZED THAT SHE SKIPPED BREAKFAST, HAD A LOT OF COFEE (1BIG MUG) AND RAN 5MILES. DENIES ANY PAIN , NO INDICATORS OF PAIN PRESENT. NO S/SX OF ANY RESPIRATORY DISTRESS. BREATHING IS EVEN AND UNLABORED. 4LEAD EKG DONE, NSR W UNIFOCAL  PVC'S.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 24-OCT-2018, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R006209, expiry date 16-MAR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Prior to vaccination: fatigue, muscle/body aches, sore throat, runny nose/congestion, headache, cough, SOB, palpitations, tachycardia, diarrhea, metallic  smell/taste, difficulty concentrating, dizziness, insomnia. Started shortly before Covid diagnosis but had only mildly subsided and present but stable upon receiving 1st vaccination.   Rash within 2 hrs of first injection. Flu like symptoms with fever and cough 2 days after first vaccine, nose bleeds, increased cognitive changes to memory, thought process, comprehension.  Fever few hours  later following 2nd vaccine. Body stiffness, bloody oral and nasal sputum 12 hrs following 2nd vaccine, flu like symptoms, body aches and stiffness, pelvis pain, 12 hrs after 2nd vaccine.
Initial unsolicited report received from a consumer on 20 October 2016. This case involves a 50 year old male patient, who was vaccinated with a dose of FLUZONE Quadrivalent (batch number: UI440AD, expiry date: 14 August 2016, dose, dose in series, form and site of administration were not reported) via intramuscularly on 11 September 2015. Patient's Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were reported as unknown. Patient's medical history and Concomitant medications were not reported. On 11 September 2015, same time following the vaccination, the patient developed tinnitus with continuous anxiety for 6-8 months. On an unknown date, following the vaccination, the patient developed peripheral neuropathy and a persistent low grade headache. It was reported that the patient had gone to ear, nose and tongue (ENT) doctor and to a neurologist for MRI, performed lab and other tests which were all in normal range. The patient required a doctor visit. Corrective treatment included Tylenol. On an unspecified date, the patient had recovered from headache and the outcome for all other events was not recovered/not resolved. List of documents held by sender: none.
Fever of 100.8, dizzy, feel a little slow mentally, I feel like things are sideways.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and sex. The patient's medical history and current condition are not reported. It was reported that GARDASIL (Lot # and expiry date not reported) injection 120 Y of normal dose and normal route was administered on 10-APR-2014, 27-MAY-2014 and 22-JUL-2014. No adverse effects were noted. The outcome of the event is unknown. Additional information has been requested.
several hrs p/vax began w/elevated fever 104; fever dec w/APAP but not much; pt also had vomiting & dairrhea w/fever x 2 wks; c/o cough, congestion, fever, poor appetite; runny nose;
Received his first dose of Comirnaty 22Nov2021/had both a positive and negative Covid-19 test on 16Dec2021; had both a positive and negative Covid-19 test on 16Dec2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the parent.  A 16 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Nov2021 (Lot number: FF2593) at the age of 16 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Type II Diabetic" (ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 16Dec2021, outcome "unknown", described as "Received his first dose of Comirnaty 22Nov2021/had both a positive and negative Covid-19 test on 16Dec2021"; COVID-19 (medically significant) with onset 16Dec2021, outcome "unknown", described as "had both a positive and negative Covid-19 test on 16Dec2021". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (16Dec2021) positive; (16Dec2021) negative. Reporter confirmed both the positive and negative covid-19 test result happened yesterday, 16Dec2021. Someone at school had contracted covid. No additional vaccines administered on same date of the Pfizer Suspect. No prior vaccinations (within 4 weeks) were reported. Events did not require a visit to Emergency room and Physician office.  No follow-up attempts are needed. No further information is expected.
Two to three weeks after receiving the vaccine I had significant brain fog not a headache cognitive decline 80% of my waking hours; I feel sluggish it spikes with excitement exercise or movement it has been very impactful; I can't focus on anything I get a numb feeling persistent through the day worse with activity severely impacted quality of life; I'm struggling I can't drive I have to pull over; cognitive decline 80% of my waking hours; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL (Two to three weeks after receiving the vaccine I had significant brain fog not a headache cognitive decline 80% of my waking hours), SLUGGISHNESS (I feel sluggish it spikes with excitement exercise or movement it has been very impactful), HYPOAESTHESIA (I can't focus on anything I get a numb feeling persistent through the day worse with activity severely impacted quality of life), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I'm struggling I can't drive I have to pull over) and COGNITIVE DISORDER (cognitive decline 80% of my waking hours) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Two to three weeks after receiving the vaccine I had significant brain fog not a headache cognitive decline 80% of my waking hours), SLUGGISHNESS (I feel sluggish it spikes with excitement exercise or movement it has been very impactful), HYPOAESTHESIA (I can't focus on anything I get a numb feeling persistent through the day worse with activity severely impacted quality of life), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I'm struggling I can't drive I have to pull over) and COGNITIVE DISORDER (cognitive decline 80% of my waking hours). At the time of the report, FEELING ABNORMAL (Two to three weeks after receiving the vaccine I had significant brain fog not a headache cognitive decline 80% of my waking hours), SLUGGISHNESS (I feel sluggish it spikes with excitement exercise or movement it has been very impactful), HYPOAESTHESIA (I can't focus on anything I get a numb feeling persistent through the day worse with activity severely impacted quality of life), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I'm struggling I can't drive I have to pull over) and COGNITIVE DISORDER (cognitive decline 80% of my waking hours) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported. The pharmacist had undergone examination, had lab work done and MRI imaging was reported.
Patient had not been feeling well yesterday after 2nd dose of Moderna (vaccination time unknown) and had told coworkers he was feeling tired today. When walking from car at work (at vaccine site) security observed him fall in parking lot. Hit head, +loss of consciousness. Laceration noted.  RNs, MD, Pod Director and Fire rescue were all on site and responded immediately. Denied headache or blurry vision. BP 172/92. Sp02 91% on RA. AA&0x2. Oxygen applied. Repeat vitals 162/88, HR 103, O2 96%. Blood sugar 167. Ambulance called. Transported to ER.
swelling at injection site/pain, redness, swelling, and wheals below the injection site; redness/pain, redness, swelling, and wheals below the injection site; wheals/wheals below the injection site/pain, redness, swelling, and wheals below the injection site; pain at injection site/pain, redness, swelling, and wheals below the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced injection site swelling, injection site erythema, injection site wheal and injection site pain. On an unknown date, the outcome of the injection site swelling, injection site erythema, injection site wheal and injection site pain were unknown.   It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site wheal and injection site pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received the Shingrix vaccine in her left arm and stated that within 24 hours of receiving the vaccine, she had pain, redness, swelling, and wheals below the injection site. The reporter did not provide additional information as she was in a hurry and also did not want to provide DOB. The reporter did not consent to follow-up
swollen arm; rash; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) and RASH (rash) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included Allergic reaction (Shakes and fever for 2 days). Concurrent medical conditions included CLL since 2017, Food allergy, Drug allergy and Allergy NOS. Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), DONEPEZIL for Memory loss of, CARISOPRODOL (SOMA [CARISOPRODOL]) for Sleepy, TAMSULOSIN for Urination frequency of.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and RASH (rash). The patient was treated with MOMETASONE (topical) for Rash, at a dose of cream. On 31-Jan-2021, PERIPHERAL SWELLING (swollen arm) and RASH (rash) had resolved.      Treatment medication include the Mometasone cream   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: No new information On 15-Apr-2021: Added patient demographics, concomitant medications, 2nd dose information; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Tingling hand and face.; This is a spontaneous report from a contactable consumer (patient). A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiry date were not reported) via unspecified route of administration, administered in left arm on 26Feb2021 15:15 (at age of 42-year-old) as single dose, for COVID-19 immunization. Patient medical history includes high blood pressure and known allergies to Phenagen. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID. Patient concomitant medications include Lisinopril. The patient's past drug event included "Phenagen" and experienced allergies. On 26Feb2021 15:45 (30 mins after vaccination), patient experienced tingling hand and face. Patient did not receive any treatment for event. The outcome of event was resolved, on an unspecified date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Engerix-B: administered via wrong site/Engerix-B via dialysis site -portal vein instead of IM; Engerix-B via dialysis site -portal vein instead of IM; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate route of vaccination in a patient who received HBV (Engerix B) for prophylaxis.   On 06-JUL-2023, the patient received Engerix B. On 06-JUL-2023, an unknown time after receiving Engerix B, the patient experienced inappropriate route of vaccination (Verbatim: Engerix-B: administered via wrong site/Engerix-B via dialysis site -portal vein instead of IM) and intramuscular formulation administered by other route (Verbatim: Engerix-B via dialysis site -portal vein instead of IM). The outcome of the inappropriate route of vaccination and intramuscular formulation administered by other route were unknown.   Additional Information: GSK Receipt Date: 06-JUL-2023 The reporter consented to follow up. The reporter reported that a nurse administered Engerix-B via dialysis site -portal vein instead of IM, which led to inappropriate route of vaccination and intramuscular formulation administered by other route.
Within 30 minutes of 1st dose of Pfizer I started experiencing shortness of breath, shakes and tremors throughout body, chest pains and this lasted for 4 straight days. I also had tiredness and weakness and blood circulation felt "off".
After giving Varicella,Mcv4 and Tdap mo ther called clinic son had moderate rashes all over body reactions mostlikely with var no fever no other major reations so far